Cambridge Healthtech Institute’s 4th Annual

Immuno-Oncology Advances

Translational Strategies, Small Molecule Targets and Immune Profiling

June 2-4, 2020


Immuno-oncology research and the subsequent development of immunotherapies continue to rapidly advance the fight against cancer. First-generation agents that achieved remarkable clinical success have inspired researchers to pursue a variety of new treatment modalities and created a robust development landscape centered on combinations strategies. The 4th Annual Immuno-Oncology Advances conference, part of World Pharma Week, will feature three key areas that include preclinical and translational strategies, small molecule targets in immuno-oncology, and immune profiling and monitoring.

 

Coverage will include, but is not limited to:

 

Translational Strategies in Immuno-Oncology

  • Reverse translational studies to guide cancer combination strategies
  • Leveraging the best of industry and academia to create new cancer medicines
  • Leveraging artificial intelligence in preclinical and translational oncology
  • Combination strategies

 

Immuno-Oncology Small Molecule Targets

  • Modulators of the innate immune system (e.g.; STING)
  • Inhibitors of immune cell metabolism
  • Nuclear receptor targets (e.g.; ROR)

 

Immune Profiling and Monitoring

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is November 22, 2019.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Marina Filshtinsnky, MD

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: 781-972-5496
Email: mfilshtinsky@healthtech.com

 

 

For partnering and sponsorship information, please contact:

Companies A-K
Rod Eymael
Manager, Business Development
Phone: 781-247-6286
Email: reymael@healthtech.com

 

Companies L-Z
Joseph Vacca, M.S.
Director, Business Development
Phone: 781-972-5431
Email: jvacca@healthtech.com